CIK 0001100682
- Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- Operating
- EIN
- 061397316
- Phone
- +1 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,127,838
- in 5 filings, $20.1M under 10b5-1 plans
Net −$20,124,864. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +3,846 | $109.34 | $421K | 29,665 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +3,304 | $144.67 | $478K | 32,969 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +1,815 | $179.66 | $326K | 34,784 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Sale | −3,825 | $281.49 | $1.1M | 30,959 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Sale | −2,606 | $282.56 | $736K | 28,353 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Sale | −1,289 | $283.41 | $365K | 27,064 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Sale | −858 | $284.58 | $244K | 26,206 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Sale | −387 | $285.16 | $110K | 25,819 |
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −3,846 | 0 | ||
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −3,304 | 3,305 | ||
| 2022-03-03 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −1,815 | 5,446 | ||
| 2022-02-28 | Smith David Ross Corporate Executive VP & CFO | Grant or award | +5,152 | 25,819 | ||
| 2022-02-23 | Smith David Ross Corporate Executive VP & CFO | Shares withheld for taxes | −374 | $289.58 | $108K | 20,667 |
| 2022-02-22 | Smith David Ross Corporate Executive VP & CFO | Shares withheld for taxes | −341 | $293.61 | $100K | 21,041 |
| 2022-01-28 | Smith David Ross Corporate Executive VP & CFO | Grant or award | +12,321 | 26,746 | ||
| 2022-01-28 | Smith David Ross Corporate Executive VP & CFO | Shares withheld for taxes | −5,364 | $312.24 | $1.7M | 21,382 |
| 2021-08-09 | Smith David Ross Corporate Executive VP & CFO | Sale | −600 | $406.36 | $244K | 15,575 |
| 2021-08-09 | Smith David Ross Corporate Executive VP & CFO | Sale | −1,150 | $407.95 | $469K | 14,425 |
| 2021-05-28 | Smith David Ross Corporate Executive VP & CFO | Grant or award | +1,313 | 16,175 | ||
| 2021-05-28 | Smith David Ross Corporate Executive VP & CFO | Grant or award · Stock Options (Right to Buy) | +4,058 | $337.99 | $1.4M | 4,058 |
Page 1 of 4 · 79 trades